Stock ANAB ANAPTYSBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart AnaptysBio, Inc.

Equities

ANAB

US0327241065

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
25.01 USD -0.24% Intraday chart for AnaptysBio, Inc. +4.25% +16.76%
May. 09 AnaptysBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 09 Anaptys Announces Positive Top-Line Gemini-2 Phase 3 Clinical Trial Results of imsidolimab (IL-36R) in Generalized Pustular Psoriasis CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ANAPTYSBIO, INC.
Bio Therapeutic Drugs
-0.24%+4.25%+16.76%+30.74%-63.52% 683M
Bullish
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. ANAB Stock
  4. Charts AnaptysBio, Inc.
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW